A Study of PSB205 in Subjects With Advanced Solid Tumors

Clinical trial NCT03986606 · UNKNOWN

Trial details

NCT number: NCT03986606
Sponsor: Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Malignant

Start date: 2019-07-05
Primary completion: 2021-02-28
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.